CD274 and hepatocellular carcinoma: In contrast to other tumor entities, PD-L1 blockage did not significantly prolong HCC patient survival, suggesting that PD-L1/PD-1 axis blockade alone may not be sufficient to initiate adequate levels of anticancer immunity in HCC [44,45].